http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3821381-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1973-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1974-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5509678f429b0c3bd4a54ea5af727caa |
| publicationDate | 1974-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3821381-A |
| titleOfInvention | Method of treatment |
| abstract | A composition for and a method of inhibiting indoleamine-Nmethyl transferase comprising the administration to a host of a therapeutically effective amount of a compound selected from the group consisting of 2,3-dimercaptoquinoxaline, 2,3,4,6,7,8hexahydropyrrolo(1,2-a)pyrimidine, Mono-lower alkyl derivatives of 2,3,4,6,7,8-hexahydropyrrolo-(1,2-a)pyrimidine, quinoclidine, 1-pyrrolidinecarboxamidine, 3,4,6,7,8,9-hexahydro-2H-pyrido(1,2a)pyrimidine, 2,3,4,6,7,8,9,10-octahydropyrimido(1,2-a)azepine, 1-methyl-2-trans-styryl-1,4,5,6-tetrahydropyrimidine, (2,4dihydroxy-5-pyrimidyl)-disulfide, 2,3-dimethoxy-5-methyl-6bromobenzoquinone and the pharmaceutically acceptable salts thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4025625-A |
| priorityDate | 1972-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.